Centroblastic diffuse large B cell lymphoma displays distinct expression pattern and prognostic role of apoptosis resistance related proteins

Cancer Investigation
Roberta Soares FaccionRaquel Ciuvalschi Maia

Abstract

Centroblastic diffuse large B cell lymphoma (DLBCL) samples were analyzed by immunohistochemistry to evaluate the expression of p53, Bcl-2, Survivin, XIAP, and Ki-67. Survivin was the only protein which expression exhibited a trend for impact in progression-free (p = .077) and overall survival (p = .054). In the Mann-Whitney test, Survivin expression correlated with a negative overall survival (p = .045). These results appeared to be intimately related to Survivin cytoplasmic localization. Moreover, the anti-apoptotic proteins Bcl-2 and Survivin were less frequent in centroblastic DLBCL. Our results indicate that centroblastic DLBCL may be a disease with characteristic biology and clinical course and, therefore, specific prognostic factors.

References

Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D EliyahuM Oren
Jan 15, 1983·International Journal of Cancer. Journal International Du Cancer·J GerdesH Stein
Mar 1, 1995·Leukemia & Lymphoma·M A PirisP Martinez
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jul 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M H KramerP M Kluin
Aug 1, 1997·Nature Medicine·G AmbrosiniD C Altieri
Jun 6, 1998·The Journal of Biological Chemistry·G AmbrosiniD C Altieri
May 15, 1998·European Journal of Haematology·A SalarA Grañena
May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E SanchezM A Piris
Jun 1, 1999·Leukemia & Lymphoma·O MonniS Knuutila
Feb 1, 2000·Journal of Cellular Physiology·T Scholzen, J Gerdes
Jun 6, 2000·Experimental Cell Research·E Endl, J Gerdes
Aug 10, 2000·The Journal of Biological Chemistry·R DattaD Kufe
Feb 15, 2001·Nature Cell Biology·P ListonR G Korneluk
Feb 24, 2001·Journal of Molecular Biology·K Phillips, B Luisi
Oct 18, 2002·Immunology·Liliana Guzman-RojasHector Martinez-Valdez
Apr 30, 2003·Nature Immunology·Joseph T Opferman, Stanley J Korsmeyer
May 13, 2003·International Journal of Cancer. Journal International Du Cancer·Ingo KauschAndreas Böhle
May 16, 2003·American Journal of Hematology·Sang Kyun SohnKyu Bo Lee
Aug 20, 2003·Molecular Biology of the Cell·Reiko HondaErich A Nigg
Jun 3, 2004·The Lancet Oncology·Bryan T HennessyPeter A Daly
Jun 26, 2004·The Journal of Biological Chemistry·Takehiko DohiDario C Altieri
Sep 14, 2004·Oncogene·Zhanxiang WangLouis M Pelus
Jun 21, 2005·Journal of Cellular and Molecular Medicine·Nadia ZaffaroniMaria Grazia Daidone
Jul 26, 2005·Annals of Hematology·Katrien VermeulenZwi N Berneman
Sep 7, 2005·Seminars in Liver Disease·John M Vierling
Dec 20, 2005·Human Pathology·Barbara VischioniGiuseppe Giaccone
May 17, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H Stein, M Hummel
Mar 8, 2007·Carcinogenesis·Marzia PennatiNadia Zaffaroni

❮ Previous
Next ❯

Citations

Aug 20, 2015·Journal of Cancer Research and Clinical Oncology·Paloma Silva de SouzaRaquel Ciuvalschi Maia
Jan 28, 2018·Cellular Oncology (Dordrecht)·Roberta Soares FaccionRaquel Ciuvalschi Maia

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis